Application Nr Approved Date Route Status External Links
ANDA077464 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Lamivudine Tablets Are A Nucleoside Analogue Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection. Limitations Of Use: The Dosage Of This Product Is For Hiv-1 And Not For Hbv. Lamivudine Tablets Are A Nucleoside Analogue Reverse Transcriptase Inhibitor Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection. Limitations Of Use: The Dosage Of This Product Is For Hiv-1 And Not For Hbv. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Lamivudine LAMIVUDINE ZINC12346

Comments